These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1180 related items for PubMed ID: 31501036

  • 21. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
    Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, Wahlgren N, Ahmed N, SITS Investigators.
    Stroke; 2012 Jun; 43(6):1524-31. PubMed ID: 22442178
    [Abstract] [Full Text] [Related]

  • 22. Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue-plasminogen activator using SEDAN score.
    Al-Khaled M, Langner B, Brüning T.
    Acta Neurol Scand; 2016 Apr; 133(4):239-44. PubMed ID: 26033162
    [Abstract] [Full Text] [Related]

  • 23. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
    Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, Sandercock P, IST-3 Collaborative Group.
    Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
    [Abstract] [Full Text] [Related]

  • 24. Cohort-Based Identification of Predictors of Symptomatic Intracerebral Hemorrhage After IV Thrombolysis.
    Asuzu D, Nyström K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN.
    Neurocrit Care; 2015 Dec; 23(3):394-400. PubMed ID: 25691004
    [Abstract] [Full Text] [Related]

  • 25. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.
    Van Hooff RJ, Nieboer K, De Smedt A, Moens M, De Deyn PP, De Keyser J, Brouns R.
    Clin Neurol Neurosurg; 2014 Oct; 125():189-93. PubMed ID: 25171393
    [Abstract] [Full Text] [Related]

  • 26. Modest association between the discharge modified Rankin Scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Asuzu D, Nystrom K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN.
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):548-53. PubMed ID: 25540072
    [Abstract] [Full Text] [Related]

  • 27. Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry.
    Mundiyanapurath S, Hees K, Ahmed N, Wahlgren N, Uhlmann L, Kieser M, Ringleb PA, Hacke W, Nagel S.
    Eur J Neurol; 2018 Feb; 25(2):340-e11. PubMed ID: 29105904
    [Abstract] [Full Text] [Related]

  • 28. Glycosylated hemoglobin A1 predicts risk for symptomatic hemorrhage after thrombolysis for acute stroke.
    Rocco A, Heuschmann PU, Schellinger PD, Köhrmann M, Diedler J, Sykora M, Nolte CH, Ringleb P, Hacke W, Jüttler E.
    Stroke; 2013 Aug; 44(8):2134-8. PubMed ID: 23715962
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. External validation of different predictive scores for symptomatic intracranial hemorrhage after intravenous thrombolysis in Asian stroke patients.
    Lin Y, Guo Y, Han J.
    Clin Neurol Neurosurg; 2024 Oct; 245():108500. PubMed ID: 39116795
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N, SITS investigators.
    Neurology; 2012 Mar 20; 78(12):880-7. PubMed ID: 22402853
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
    Vandelli L, Marietta M, Trenti T, Varani M, Bigliardi G, Rosafio F, Dell'acqua ML, Picchetto L, Nichelli P, Zini A.
    Adv Clin Exp Med; 2019 Feb 20; 28(2):219-222. PubMed ID: 30507073
    [Abstract] [Full Text] [Related]

  • 36. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov 20; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
    Cappellari M, Turcato G, Forlivesi S, Zivelonghi C, Bovi P, Bonetti B, Toni D.
    Stroke; 2018 Feb 20; 49(2):397-404. PubMed ID: 29311264
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A new nomogram for individualized prediction of the probability of hemorrhagic transformation after intravenous thrombolysis for ischemic stroke patients.
    Wu Y, Chen H, Liu X, Cai X, Kong Y, Wang H, Zhou Y, Zhu J, Zhang L, Fang Q, Li T.
    BMC Neurol; 2020 Nov 24; 20(1):426. PubMed ID: 33234113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.